• News
  • SAN DIEGO
  • Finance

Medical-products maker Baxter falls to loss; will restate results

DEERFIELD, Ill. (Dow Jones/AP) - Baxter International Inc., a maker of medical products, sank to a loss in the second quarter as a hefty restructuring charge hurt its bottom line.

The Deerfield-based company also said Thursday it will restate earnings from 2001 through 2003 mainly because of an error in the way it recognizes revenue and inadequate bad-debt provisions in Brazil.

For the latest quarter, Baxter posted a loss of $170 million, or 28 cents a share, compared with profit of $38 million, or 6 cents a share, in the same quarter a year ago.

The latest results included restructuring and other charges of $414 million, or 68 cents a share.

In January, Baxter said it would cut about 4,000 jobs, or about 8 percent of its work force. It also will reduce plasma production by 13 percent a year as it closes certain collection centers.

Excluding the charges, Baxter said it would have reported second-quarter earnings of $245 million, or 40 cents a share, matching the average estimate of analysts polled by Thomson First Call.

Sales for the latest quarter rose 10 percent to $2.38 billion from $2.16 billion a year ago.

The restatement will reduce net income for 2001 through 2003 by no more than $40 million, or 7 cents a share, Baxter said.

For the first six months of the year, Baxter had net income of $8 million, or 1 cent a share, compared with $254 million, or 42 cents a share, a year before.

Shares of Baxter closed Thursday at $30.79, down $1.48, or 4.6 percent, on the New York Stock Exchange.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Subscribe Today!